{"schema_version":"secwatch.filing_event.v1","accession":"0001522767-25-000222","form_type":"8-K","ticker":"MRMD","cik":"0001522767","company_name":"MARIMED INC.","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.626347+00:00","generated_at":"2026-05-17T00:15:50.129248+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"MariMed Q3 revenue $40.8M, adjusted EBITDA $5.1M; expands brands to 3 new states","bullets":["Revenue flat at $40.8M (Q3 2024: $40.6M); GAAP net loss widened to $2.9M from $1.0M.","Adjusted EBITDA rose to $5.1M from $4.7M; margin improved to 13% from 12% YoY.","Sequential growth in wholesale and retail; new brand distribution agreements in Maine, Pennsylvania, and New York.","Delaware adult-use sales launched; Metropolis, IL location impacted by new competition.","Nine-month revenue $118.2M vs $118.8M; GAAP net loss $9.8M vs $4.2M."],"urls":{"canonical":"https://secwatch.observer/filing/0001522767-25-000222","json":"https://secwatch.observer/filing/0001522767-25-000222.json","markdown":"https://secwatch.observer/filing/0001522767-25-000222.md","text":"https://secwatch.observer/filing/0001522767-25-000222.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1522767/000152276725000222/0001522767-25-000222-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1522767/000152276725000222/mrmd-20251105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:15:50.129248+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}